Faridabad-based health technology startup Medimetry has raised an undisclosed amount in seed funding led by US-headquartered hedge fund BlueSky Capital Management.
Launched in 2014, by IIT alumnus Krishan Tyagi and his wife Dr Bhawana Tyagi, Medimettry offers an online platform for telemedicine, electronic medical records and disease management.
The company started out as an online doctor consultation platform that connects doctors with patients in real time. It is now building a digital disease management platform for chronic ailments. Medimetry has a mobile app and web portal that enable patients to chat with doctors at their convenience – from anywhere, at anytime.
Currently operational in Delhi-NCR, Medimetry plans to use the fresh capital for sales, marketing and to upgrade its digital disease management platform.
Beside Tier-1 cities, Medimetry also aims to solve the problem of accessibility and convenience in smaller towns and rural areas. Most villages do not have a hospital and residents have to travel quite a distance to access healthcare. “We want to educate these markets so that their problems can be solved through a medical app and they don’t have to travel. So the aim is to expand not just to tier 3 but rural areas as well,” Krishan says in a statement to a daily last year.
About Bluesky Capital, it is a US-headquartered investment firm that backs high-potential teams, technologies and business models with a particular focus on mobile and security-related technologies targeting the financial services and payment sectors.
Bluesky’s target investment size is $200,000 to $2 million with the potential for additional commitments in follow-on financing.
Earlier this month, New Delhi-based fertility healthcare platform ElaWoman raised $3 million in series A funding round led by Chiratae Ventures (formerly IDG Ventures India), along with Alkemi Venture Partners.
In August, Bengaluru based healthtech firm, HealthPlix, that assists doctors digitally, had raised $3 Million from IDG Ventures India and Kalaari Capital.
To Read Our Daily News Updates, Please Visit Inventiva Or Subscribe Our Newsletter & Push.